Collegium Pharmaceutical, Inc (NASDAQ:COLL) has 274 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -78,342 | -1.51% | $0.00 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 31 Dec, 2025 | 0 | 1,497,470 | 99.65% | $0.00 |
| Rubric Capital Management LP | 31 Dec, 2025 | 0 | -1,330,062 | -47.06% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -45,474 | -30.50% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 29,876 | 1.34% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -52,317 | -16.32% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 44,374 | 255.99% | $0.00 |
| EVENTIDE ASSET MANAGEMENT, LLC | 31 Dec, 2025 | 0 | -514,673 | -21.53% | $0.00 |
| Pacer Advisors, Inc. | 31 Dec, 2025 | 0 | -9,711 | -3.88% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | -16 | -5.26% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | 18,160 | 1.14% | $0.00 |
| Trexquant Investment LP | 31 Dec, 2025 | 0 | 150,602 | 0.00% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 538,337 | 59.14% | $0.00 |
| Ballast Asset Management, LP | 31 Dec, 2025 | 0 | -3,872 | -3.39% | $0.00 |
| Principal Financial Group Inc | 31 Dec, 2025 | 0 | 3,891 | 0.30% | $0.00 |
| ExodusPoint Capital Management, LP | 31 Dec, 2025 | 0 | 89,383 | 565.64% | $0.00 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 31 Dec, 2025 | 0 | 518,721 | 65.34% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -159,572 | -62.46% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 16,730 | 1.29% | $0.00 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 31 Dec, 2025 | 0 | -3,460 | -3.61% | $0.00 |